Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 10;10(8):1370.
doi: 10.3390/children10081370.

Comparative Analysis of Hematological and Biochemical Changes in Neonates among Women with and without COVID-19 Infection during Pregnancy

Affiliations

Comparative Analysis of Hematological and Biochemical Changes in Neonates among Women with and without COVID-19 Infection during Pregnancy

Daniela-Eugenia Popescu et al. Children (Basel). .

Abstract

The aim of this study is to evaluate the test results of neonates delivered by COVID-19-positive mothers during pregnancy with those of neonates born to unvaccinated mothers who are COVID-19-free. A cohort study was conducted on 367 pregnant women who gave birth at Premiere Hospital, Timisoara, Romania, between May 2021 and February 2022. Two groups were established: Group 1, with 167 pregnant women infected with COVID-19, and Group 2, with 200 pregnant women who were not affected by COVID-19 during pregnancy. Maternal laboratory examination did not exhibit significant variations except for platelet count. In neonatal blood tests, WBC had a significantly lower median value in the group born to COVID-19-free mothers. Neonatal anemia and leukocytosis showed slightly higher prevalence in Group 1, but the differences were not statistically significant. This study suggests that maternal COVID-19 infection during pregnancy does not have significant associations with most maternal and neonatal characteristics.

Keywords: COVID-19; pregnancy complications; vertical transmission.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparative analysis of neonatal laboratory test medians according to the presence of COVID-19 symptoms: (a) Hematological tests; (b) Biochemical laboratory tests. Note: Black dots represent outliers; The whiskers extend from the minimum to the lower quartile and from the upper quartile to the maximum; Red colour represents hematological tests and and blue colour biochemical blood tests.
Figure 2
Figure 2
Comparative analysis of neonatal laboratory test medians according to the presence of COVID-19 hospitalization: (a) Hematological tests; (b) Biochemical laboratory tests. Note: Black dots represent outliers; The whiskers extend from the minimum to the lower quartile and from the upper quartile to the maximum; Red colour represents hematological tests and and blue colour biochemical blood tests.
Figure 3
Figure 3
Comparative analysis of neonatal laboratory test medians according to the trimester of maternal infection with COVID-19. Note: Black dots represent outliers; The whiskers extend from the minimum to the lower quartile and from the upper quartile to the maximum; Red colour represents hematological tests and and blue colour biochemical blood tests.
Figure 4
Figure 4
Correlation matrix plot presenting pairwise correlation coefficients between neonatal hematological, biochemical, and immunological findings. Note: Sign “?” = “not applicable”; as none of the participants were tested for both IgG and anti-S antibodies.

Similar articles

Cited by

References

    1. Sawicka B., Aslan I., Della Corte V., Periasamy A., Krishnamurthy S.K., Mohammed A., Tolba Said M.M., Saravanan P., Del Gaudio G., Adom D., et al. Chapter 14—The Coronavirus Global Pandemic and Its Impacts on Society. In: Egbuna C., editor. Coronavirus Drug Discovery. Volume 1. Elsevier; Amsterdam, The Netherlands: 2022. pp. 267–311. Drug Discovery Update. - DOI
    1. The Impact of COVID-19 on Global Health Goals. [(accessed on 6 July 2023)]. Available online: https://www.who.int/news-room/spotlight/the-impact-of-covid-19-on-global....
    1. Allotey J., Fernandez S., Bonet M., Stallings E., Yap M., Kew T., Zhou D., Coomar D., Sheikh J., Lawson H., et al. Clinical Manifestations, Risk Factors, and Maternal and Perinatal Outcomes of Coronavirus Disease 2019 in Pregnancy: Living Systematic Review and Meta-Analysis. BMJ. 2020;370:m3320. doi: 10.1136/bmj.m3320. - DOI - PMC - PubMed
    1. Chaubey I., Vignesh R., Babu H., Wagoner I., Govindaraj S., Velu V. SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission. Front. Cell. Infect. Microbiol. 2021;11:717104. doi: 10.3389/fcimb.2021.717104. - DOI - PMC - PubMed
    1. Gomez U.T., Francisco R.P.V., Baptista F.S., Gibelli M.A.B.C., Ibidi S.M., Carvalho W.B.D., Paganoti C.D.F., Sabino E.C., Silva L.C.D.O.D., Jaenisch T., et al. Impact of SARS-CoV-2 on Pregnancy and Neonatal Outcomes: An Open Prospective Study of Pregnant Women in Brazil. Clinics. 2022;77:100073. doi: 10.1016/j.clinsp.2022.100073. - DOI - PMC - PubMed

LinkOut - more resources